U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
LETOLIZUMAB
INN   USAN  
USAN   INN  
Official Name English
letolizumab [INN]
Preferred Name English
IMMUNOGLOBULIN (SYNTHETIC LIGHT CHAIN VARIABLE REGION FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G (SYNTHETIC FC FRAGMENT), NONCOVALENTLY LINKED DIMER
Systematic Name English
Letolizumab [WHO-DD]
Common Name English
LETOLIZUMAB [USAN]
Common Name English
BMS-986004
Code English
Code System Code Type Description
SMS_ID
300000021868
Created by admin on Tue Apr 01 19:52:34 GMT 2025 , Edited by admin on Tue Apr 01 19:52:34 GMT 2025
PRIMARY
INN
10436
Created by admin on Tue Apr 01 19:52:34 GMT 2025 , Edited by admin on Tue Apr 01 19:52:34 GMT 2025
PRIMARY
USAN
CD-173
Created by admin on Tue Apr 01 19:52:34 GMT 2025 , Edited by admin on Tue Apr 01 19:52:34 GMT 2025
PRIMARY
WIKIPEDIA
Letolizumab
Created by admin on Tue Apr 01 19:52:34 GMT 2025 , Edited by admin on Tue Apr 01 19:52:34 GMT 2025
PRIMARY
NCI_THESAURUS
C120140
Created by admin on Tue Apr 01 19:52:34 GMT 2025 , Edited by admin on Tue Apr 01 19:52:34 GMT 2025
PRIMARY
FDA UNII
449MIE2SD6
Created by admin on Tue Apr 01 19:52:34 GMT 2025 , Edited by admin on Tue Apr 01 19:52:34 GMT 2025
PRIMARY
CAS
1450981-87-9
Created by admin on Tue Apr 01 19:52:34 GMT 2025 , Edited by admin on Tue Apr 01 19:52:34 GMT 2025
PRIMARY
ACTIVE MOIETY
LETOLIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966